BioSpace News Archive

Most of the jobs are field-based positions across the U.S., although some will be in Thousand Oaks, California at the company’s headquarters.

Companies from across the globe provide updates on their businesses and pipelines.

Accurate and detailed protein interactions analysis under near-native conditions with an easy-to-use system

At the center of the agreement are Dragonfly’s novel NK cell engager-based immunotherapies.

Kymera Therapeutics Inc., a biotechnology company pioneering targeted protein degradation to discover breakthrough therapies for patients, today announced Kymera Co-founder, President and Chief Scientific Officer Nello Mainolfi, PhD, has been promoted to President and Chief Executive Officer effective immediately

Sierra Oncology, Inc. (Nasdaq: SRRA), a late-stage drug development company focused on the development and commercialization of momelotinib, a JAK1, JAK2 & ACVR1 inhibitor with a potentially differentiated therapeutic profile for the treatment of myelofibrosis, today announced that it has launched the MOMENTUM clinical trial for patients with myelofibrosis

InformedDNA®, the nation’s largest independent provider of genetics services, today released details of its Coverage Decision Framework™ which enables health plans to offer members improved access to emerging genetic tests.

MYOS RENS Technology Inc. (“MYOS” or “the Company”) (NASDAQ: MYOS), announced today that an abstract based on the results from a clinical trial evaluating the impact of Fortetropin

ReForm Biologics, a pharmaceutical technology company developing innovative platforms to improve biologic formulations, expanded its patent portfolio with the issuance of U.S. Patent No. 10,478,498 (the ‘498 patent)

Relationship brings to life United Imaging’s vision, commitment to increased access to medical imaging